罗瑞雅贝？

IVD资讯11-14

来源：体外诊断观察10月22日，丹纳赫公布了Q3财报。前三季度营收173.37亿美元（约1245亿元人民币），净利润28.13亿美元（约202亿元人民币）。其中技术业务营收48.90亿美元，生命科学业务营收52.97亿美元，医学诊断业务营收71.50亿美元（约513亿元人民币），占比总营收41.24%。雅培诊断业务前三季度营收68.21亿美元（约488亿元人民币），同比下跌5.6%，不考虑新冠业务...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2483816611?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-14 13:45","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2483816611","market":"us","top_or_hot":-1,"title":"罗瑞雅贝？","media":"IVD资讯","content":"<div>\n<p>来源：体外诊断观察10月22日，丹纳赫公布了Q3财报。前三季度营收173.37亿美元（约1245亿元人民币），净利润28.13亿美元（约202亿元人民币）。其中技术业务营收48.90亿美元，生命科学业务营收52.97亿美元，医学诊断业务营收71.50亿美元（约513亿元人民币），占比总营收41.24%。雅培诊断业务前三季度营收68.21亿美元（约488亿元人民币），同比下跌5.6%，不考虑新冠业务...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114134557abbfbbe8&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>罗瑞雅贝？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n罗瑞雅贝？\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 13:45 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114134557abbfbbe8&s=b><strong>IVD资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>来源：体外诊断观察10月22日，丹纳赫公布了Q3财报。前三季度营收173.37亿美元（约1245亿元人民币），净利润28.13亿美元（约202亿元人民币）。其中技术业务营收48.90亿美元，生命科学业务营收52.97亿美元，医学诊断业务营收71.50亿美元（约513亿元人民币），占比总营收41.24%。雅培诊断业务前三季度营收68.21亿美元（约488亿元人民币），同比下跌5.6%，不考虑新冠业务...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114134557abbfbbe8&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0289960550.SGD","symbol_name":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114134557abbfbbe8&s=b","article_id":"2483816611","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114134557abbfbbe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2483816611","pubTimestamp":1731563130,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"就诊断业务营收来说，丹纳赫在2024年前三季度营收已经超过雅培，成为全球排名第二。罗氏诊断2024年中国区营收约为208亿元人民币，雅培诊断2024年中国区营收约为65亿元人民币，迈瑞诊断2024年中国区109亿元人民币。就中国区诊断业务而言，罗氏＞迈瑞＞丹纳赫＞雅培。如果将罗氏、迈瑞、贝克曼库尔特、雅培四家公司在中国区诊断业务进行排名的话，大致是罗氏＞迈瑞＞雅培＞贝克曼库尔特。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","BK4581":"高盛持仓","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","BK4504":"桥水持仓","ABT":"雅培","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU0528227936.USD":"富达环球人口趋势基金A-ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU2211814178.USD":"ALLIANZ CLEAN PLANET \"AT\" (USD) ACC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0312595415.SGD":"Schroder ISF Global Climate Change Equity A Acc SGD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4585":"ETF&股票定投概念","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU0107464264.USD":"abrdn SICAV I - GLOBAL INNOVATION EQUITY \"A\" (USD) ACC","LU1721429741.USD":"BNP PARIBAS SMART FOOD \"CRH\" (USD) INC","LU0882574055.USD":"富达全球健康医疗A ACC","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU2125910179.SGD":"Natixis Thematics Water H-R/A SGD","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","BK4566":"资本集团","LU2063271972.USD":"富兰克林创新领域基金","SG9999002224.SGD":"Allianz Global High Payout SGD","LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","BK4082":"医疗保健设备","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","BK4121":"生命科学工具和服务","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","DHR":"丹纳赫","LU1923621640.USD":"Natixis Thematics Water R/A USD","BK4568":"美国抗疫概念"},"translate_title":"Lori Yabe?","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DHR":0.9,"ABT":0.89},"content_text":"来源：体外诊断观察10月22日，丹纳赫公布了Q3财报。前三季度营收173.37亿美元（约1245亿元人民币），净利润28.13亿美元（约202亿元人民币）。其中技术业务营收48.90亿美元，生命科学业务营收52.97亿美元，医学诊断业务营收71.50亿美元（约513亿元人民币），占比总营收41.24%。雅培诊断业务前三季度营收68.21亿美元（约488亿元人民币），同比下跌5.6%，不考虑新冠业务影响的话，则同比上涨4.8%。就诊断业务营收来说，丹纳赫在2024年前三季度营收已经超过雅培，成为全球排名第二。丹纳赫在三季报及半年报中，均未披露中国市场相关数据，所以只能根据2023年年度报告数据进行推测。丹纳赫超越雅培，迈瑞名列第二，中国IVD“新四大家”格局形成。2023年丹纳赫中国区总营收为31.43亿美元，占比总营收13.16%，假设2024年丹纳赫中国区营收占比总营收维持不变，则可推算出，2024年前三季度丹纳赫中国区总营收为22.80亿美元（约164亿元人民币）。假设丹纳赫中国区诊断业务占比中国区总营收，与全球诊断业务占比全球总营收一致，均为41.24%的话，则可推算出丹纳赫中国区诊断业务营收约为9.40亿美元（约68亿元人民币）。假设丹纳赫第四季度营收约为前三季度营收平均值的话，则可推算出丹纳赫2024年中国区营收约为90亿元人民币（仅供参考）。罗氏诊断2024年中国区营收约为208亿元人民币，雅培诊断2024年中国区营收约为65亿元人民币，迈瑞诊断2024年中国区109亿元人民币。(以上数据均为推算，仅供参考，具体请以企业最终披露年报数据为准)就中国区诊断业务而言，罗氏＞迈瑞＞丹纳赫＞雅培。不过丹纳赫是一家集团企业，旗下贝克曼库尔特、赛沛、雷度米特、徕卡等子公司在中国有开展业务，其中贝克曼库尔特占据丹纳赫在中国区诊断业务的大部分份额。如果将罗氏、迈瑞、贝克曼库尔特、雅培四家公司在中国区诊断业务进行排名的话，大致是罗氏＞迈瑞＞雅培＞贝克曼库尔特。声明：本微信注明来源的稿件均为转载，仅用于分享，不代表平台立场，如涉及版权等问题，请尽快联系我们，我们第一时间更正，谢谢。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483816611"}